CORCEPT THERAPEUTICS INC: 10-K filed 2015-03-13
What CORCEPT THERAPEUTICS INC reported in its annual report filed 2015-03-13 (fiscal FY 2014): 31 published measures, 93 facts as tagged in accession 0001562762-15-000080.
This filing
- Form
- 10-K (annual report)
- Filed
- 2015-03-13
- Fiscal period
- fiscal FY 2014
- Accession
- 0001562762-15-000080 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORCEPT THERAPEUTICS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 34,630,000 | USD | |
| At 2013-12-31 | 63,077,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -3,388,000 | USD | |
| At 2013-12-31 | 21,017,000 | USD | |
| At 2012-12-31 | 61,777,000 | USD | |
| At 2011-12-31 | 34,807,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 24,248,000 | USD | |
| At 2013-12-31 | 54,877,000 | USD | |
| At 2012-12-31 | 93,032,000 | USD | |
| At 2011-12-31 | 39,635,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -3,895,000 | USD | 92 |
| 2014-01-01 to 2014-12-31 | -31,383,000 | USD | 365 |
| 2014-07-01 to 2014-09-30 | -6,006,000 | USD | 92 |
| 2014-04-01 to 2014-06-30 | -7,552,000 | USD | 91 |
| 2014-01-01 to 2014-03-31 | -13,930,000 | USD | 90 |
| 2013-10-01 to 2013-12-31 | -11,124,000 | USD | 92 |
| 2013-01-01 to 2013-12-31 | -46,011,000 | USD | 365 |
| 2013-07-01 to 2013-09-30 | -10,906,000 | USD | 92 |
| 2013-04-01 to 2013-06-30 | -11,897,000 | USD | 91 |
| 2013-01-01 to 2013-03-31 | -12,084,000 | USD | 90 |
| 2012-01-01 to 2012-12-31 | -38,048,000 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 174,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 127,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 151,000 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -324,000,000 | USD | |
| At 2013-12-31 | -292,617,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 236,000 | USD | |
| At 2013-12-31 | 203,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 5,201,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 5,196,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 5,310,000 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -27,619,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -41,496,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -36,272,000 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 30,230,000 | USD | |
| At 2013-12-31 | 58,311,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 13,555,000 | USD | |
| At 2013-12-31 | 12,738,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,886,000 | USD | |
| At 2013-12-31 | 2,381,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 3,334,000 | USD | |
| At 2013-12-31 | 1,428,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 54,170,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 51,853,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 39,579,000 | USD | 366 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,207,000 | USD | |
| At 2013-12-31 | 1,096,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 8,755,000 | USD | 92 |
| 2014-07-01 to 2014-09-30 | 7,047,000 | USD | 92 |
| 2014-04-01 to 2014-06-30 | 5,636,000 | USD | 91 |
| 2014-01-01 to 2014-03-31 | 4,231,000 | USD | 90 |
| 2013-10-01 to 2013-12-31 | 4,055,000 | USD | 92 |
| 2013-07-01 to 2013-09-30 | 2,594,000 | USD | 92 |
| 2013-04-01 to 2013-06-30 | 1,868,000 | USD | 91 |
| 2013-01-01 to 2013-03-31 | 1,697,000 | USD | 90 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 882,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 143,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 91,000 | USD | 366 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 34,916,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 31,240,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 25,414,000 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 18,372,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 20,470,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 14,074,000 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 101,395,000 | shares | |
| At 2013-12-31 | 99,849,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 320,511,000 | USD | |
| At 2013-12-31 | 313,534,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 525,000 | USD | |
| At 2013-12-31 | 351,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 289,000 | USD | |
| At 2013-12-31 | 148,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 74,000 | USD | |
| At 2013-12-31 | 113,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,876,000 | USD | |
| At 2013-12-31 | 1,301,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,441,000 | USD | |
| At 2013-12-31 | 910,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -31,383,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -46,011,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -38,048,000 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 141,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 74,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 27,000 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 1,906,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 871,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 557,000 | USD | 366 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -249,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 883,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 4,663,000 | USD | 366 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -495,000 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -1,423,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 193,000 | USD | 366 |
Inspect the source
- Entity
- CORCEPT THERAPEUTICS INC / CIK 0001088856
- Captured
- 2026-09-20T05:21:37.067Z
- SEC response SHA-256
9eeefb4ce187c5355b174f4fe6f87e573e0565fb0941138bcb8d7151ae198435
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001088856.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))